JPRN-UMIN000007019已完成未知
Efficacy and safety of tocilizumab mono-therapy in patients with adult-onset Still's disease - Treatment of AOSD by tocilizumab mono-therapy
Department of Rheumatology & Clinical Immunology,Saitama Medical Center, Saitama Medical Universitity0 个研究点目标入组 40 人开始时间: 2012年2月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)patients who are prohibited to use tocilizumab by the JCR guideline for proper tocilizumab use 2)patients who are thought to be inappropriate for the treatment with tocilizumab by their attending doctor
研究者
相似试验
已完成
不适用
Efficacy and safety of tocilizumab mono-therapy in patients with large vessel vasculitis (LVV; giant cell arteritis or Takayasu arteritis) and polymyalgia rheumatica (PMR)Rheumatoid arthritisJPRN-UMIN000008812Department of Rheumatology & Clinical Immunology Saitama Medical Center, Saitama Medical Universitity40
已完成
不适用
Efficacy and safety of tocilizumab monotherapy in patients with microscopic polyangiitisMicroscopic polyangiitisJPRN-UMIN000011242Saitama Medical Center, Saitama Medical University Department of Rheumatology and Clinical Immunology10
已完成
不适用
Efficacy and Safety of treatment with tocilizumab in refractory patients with Takayasu ArteritisTakayasu arteritisJPRN-UMIN000007845Department of Cardiovascular Medicine Graduate School of Medicine Osaka University15
已完成
不适用
ong-term Safety of treatment with tocilizumab in the refractory patients with Takayasu ArteritisTakayasu arteritisJPRN-UMIN000025943Osaka Unversity9
招募中
2 期
Evaluation the Efficacy and Safety of Tocilizumab in COVID-19COVID-19 pneumonia.Confirmed diagnosis of COVID-19RA01.0IRCT20151227025726N13Shahid Beheshti University of Medical Sciences40